Tissue engineering of vascularised human liver organoids: study of morphology phenotypic expression and metabolomics of transitional co-cultures of hepatic/endothelial progenitors. (13th March 2011)

• Record Type: Journal Article
• Authors: Nelson, L J; Burgess, K; Navarro, M; Tura, O; Samuel, K; Hayes, P C; Turner, M; Plevris, J N
• Is Part Of: Gut. Volume 60:(2011)Supplement 1
• Page Start: A244
• Page End: A244
• Publication Date: 2011-03-13
• Subjects: co-culture -- endothelial progenitors -- liver cell line -- liver organoids.; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gut.2011.239301.518
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Introduction: Tissue architecture and hepatic cell morphology reflect the functional differentiation of the liver. Differentiated functions of hepatocytes, depend on complex, hetereotypic cell-cell/cell-matrix interactions mediated by cell adhesion molecules (CAMs) in a 3D microenvironment. Vascularisation of human hepatic tissue for therapeutic/pharmaceutical applications, requires knowledge of optimal trophic conditions to support different cell types and how these cells behave embedded in different biocompatible matrices. Methods: The authors aimed to assess morphology, metabolic functionality and phenotypic expression of human progenitor EoCs (Endothelial outgrowth Cells) vascular microvessels, cocultured with hepatic C3A cells (C3As). EoC/C3A cocultures in different media and test biomatrices: Matrigel/MaxGel/Puramatrix (self-assembling nanofibres); and control standard 2D cultures (tissue culture plastic; TCP) were analysed following immunostaining using morphology (light/confocal microscopy); and flow cytometry. Metabolomics analysis of culture media provided a global picture of metabolic changes in response to hepatic/EoC coculture (vs reference C3A mono-cultures). Results: Titration in standard 2D/TCP co-culture in various media showed a ratio of 3C3A:1EoC in Lonza EGM-2 medium was optimal. Cells retained phenotypic expression of differentiation markers: (1) Hepatic: Albumin, EpCAM, E-CAD; (2) EoC: CD146, CD31, CD105, VWF; as evidenced by flow cytometry/immunostaining. Metabolomics analysis of media (from 2D/TCP co-cultures), showed modulation of key hepatic metabolic intermediaries including: (1) Urea cycle: 50% enhancement of L-ornithine production; (2) Biosynthesis: Bile Acids: Enhanced Glycocholate; amino acid (eg, Taurine) utilisation; and Creatine production: (3) Antioxidants: co-culture ameliorated the requirement of high Glutathione antioxidant levels inherent to EoC monocultures. Test biomatrices under different 3D culture configurations, showed: (1) MaxGel sandwich culture promoted differentiated (cuboidal) morphology of C3As, but not EoCs; (2) Conversely, only EoCs overlaid on MaxGel formed differentiated (microvessel) structures; (3) Puramatrix supported 3D culture of C3As but not EoCs; (4) Matrigel supported only EoCs 3D microtubular structures. Conclusion: This study proved informative for engineering of vascularised organoids for future clinical/pharmaceutical applications. Work in progress include comprehensive metabolomics analysis, flow cytometric profiling and combinatorial analysis of cell-supportive biomatrix configurations to further optimise 3D coculture.